Angiogenesis as a target for cancer therapy

被引:19
作者
Kaban, K [1 ]
Herbst, RS [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1016/S0889-8588(02)00047-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The necessity for tumors to create new blood vessels to grow and the restriction of normal angiogenesis in healthy adults to only a few short-lasting situations provide very selective targets for antiangiogenic cancer therapies. In contrast to the neoplastic cells in their vicinity, vascular endothelial cells are genetically stable and less likely to develop resistance to therapy. Moreover, every cancer type is virtually a unique disease and requires tailored therapy, but agents targeting the tumor endothelium, a relatively uniform and normal cell type, might be effective against a broad range of tumor types. This article reviews the biology of angiogenesis and some of the most common agents used to inhibit this process.
引用
收藏
页码:1125 / +
页数:48
相关论文
共 301 条
  • [11] Relevance of biologic markers in colorectal carcinoma - A comparative study of a broad panel
    Barozzi, C
    Ravaioli, M
    D'Errico, A
    Grazi, GL
    Poggioli, G
    Cavrini, G
    Mazziotti, A
    Grigioni, WF
    [J]. CANCER, 2002, 94 (03) : 647 - 657
  • [12] BASELGA J, 2002, 38 ANN M ASCO ORL FL
  • [13] BASSER R, 2001, 37 ANN M ASCO SAN FR
  • [14] The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
    Basu, S
    Nagy, JA
    Pal, S
    Vasile, E
    Eckelhoefer, IA
    Bliss, VS
    Manseau, EJ
    Dasgupta, PS
    Dvorak, HF
    Mukhopadhyay, D
    [J]. NATURE MEDICINE, 2001, 7 (05) : 569 - 574
  • [15] BATIST G, 2002, 38 ANN M ASCO ORL FL
  • [16] Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice
    Beecken, WDC
    Fernandez, A
    Panigrahy, D
    Achilles, EG
    Kisker, O
    Flynn, E
    Joussen, AM
    Folkman, J
    Shing, Y
    [J]. UROLOGY, 2000, 56 (03) : 521 - 526
  • [17] Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies
    Bellamy, WT
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (06) : 551 - 559
  • [18] Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
    Bellomo, D
    Headrick, JP
    Silins, GU
    Paterson, CA
    Thomas, PS
    Gartside, M
    Mould, A
    Cahill, MM
    Tonks, ID
    Grimmond, SM
    Townson, S
    Wells, C
    Little, M
    Cummings, MC
    Hayward, NK
    Kay, GF
    [J]. CIRCULATION RESEARCH, 2000, 86 (02) : E29 - E35
  • [19] Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation
    Benelli, R
    Morini, M
    Carrozzino, F
    Ferrari, N
    Minghelli, S
    Santi, L
    Cassatella, M
    Noonan, DM
    Albini, A
    [J]. FASEB JOURNAL, 2001, 15 (14) : 267 - +
  • [20] The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing
    Berger, AC
    Feldman, AL
    Gnant, MFX
    Kruger, EA
    Sim, BKL
    Hewitt, S
    Figg, WD
    Alexander, HR
    Libutti, SK
    [J]. JOURNAL OF SURGICAL RESEARCH, 2000, 91 (01) : 26 - 31